Wolfgang Brückl

Research output

Research output per year 1993 2001 2003 2005 2017 2023 2024

• 60 Original Article (Journal)
• 9 Case report
• 8 Review article
• 5 Editorial
• 4 More
  • 4 published Abstract (Journal)

Research output per year

Research output per year

Search results

• 2023

  Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives

  Reck, M., Popat, S., Grohe, C., Corral, J., Novello, S., Gottfried, M., Brueckl, W. (Co-author), Radonjic, D., Kaiser, R. & Heymach, J., 2023, In: LUNG CANCER . 179, p. 107173

  Research output: Contribution to journal › Review article › peer-review
  10 Citations (Web of Science)
• 2020

  Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).

  Brueckl, W. M. (First author), Ficker, J. H. (Co-author) & Zeitler, G., 2020, In: BMC CANCER. 20, 1, p. 1185

  Research output: Contribution to journal › Review article › peer-review
  82 Citations (Web of Science)
• 2013

  [Employing tyrosine kinase inhibitors in the first line treatment of EGFR-positive metastatic NSCLC - state of the art and recent developments].

  Wiewrodt, R., Serke, M., Grohé, C. & Brückl, W. (Last author), 2013, In: PNEUMOLOGIE. 67, 9, p. 494-501

  Research output: Contribution to journal › Review article › peer-review
• 2010

  [Current status of erlotinib and gefitinib in palliative therapy for NSCLC--does the EGF-R mutation state have any significance?].

  Brückl, W. (First author), Wiest, G. H. & Ficker, J. H. (Last author), 2010, In: PNEUMOLOGIE. 64, 12, p. 727-735

  Research output: Contribution to journal › Review article › peer-review
• 2008

  [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].

  Brückl, W. (First author), Lampert, S., Zirlik, S., Hahn, E. G. & Wiest, G. H., 2008, In: PNEUMOLOGIE. 62, 1, p. 23-30

  Research output: Contribution to journal › Review article › peer-review
• 2007

  [An approach to individualised therapy of non-small cell lung carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors].

  Zirlik, S., Lampert, S., Hahn, E. G., Wiest, G. H. & Brückl, W., 2007, In: PNEUMOLOGIE. 61, 11, p. 731-738

  Research output: Contribution to journal › Review article › peer-review
• 2000

  [Improvements in palliative treatment of colorectal carcinoma].

  Wein, A., Riedel, C., Hanke, B., Lampert, S., Brückl, W. (Co-author), Reingruber, B., Hohenberger, W. & Hahn, E. G., 2000, In: DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. 125, 5, p. 121-125

  Research output: Contribution to journal › Review article › peer-review
  3 Citations (Web of Science)

• Microsatellite instability in colorectal adenomas: relevance and clinical importance.

  Brueckl, W. M. (First author), Jung, A., Wein, A., Brabletz, T., Guenther, K., Nusko, G. & Hahn, E. G., 2000, In: INTERNATIONAL JOURNAL OF COLORECTAL DISEASE . 15, 4, p. 189-196

  Research output: Contribution to journal › Review article › peer-review

  11 Citations (Web of Science)